Drug intelligence / Profile preview

Yinqiao Jiedu Granules

Development stage
Unknown
Lead developer
Qingdao Growful Pharmaceutical
Administration
Oral
01

Overview

Yinqiao Jiedu Granules is a Traditional Chinese Medicine (TCM) formulation based on the classic Yin Qiao San prescription, primarily used for the treatment of the common cold and influenza. It is specifically indicated for wind-heat type respiratory infections characterized by symptoms such as fever, headache, cough, and sore throat. The formulation is manufactured by Shanghai Pharmaceuticals Group Qingdao Growful Pharmaceutical and is marketed as an over-the-counter (OTC) product in China. The granules are composed of several botanical extracts, including *Lonicera japonica* (honeysuckle) and *Forsythia suspensa*, which are traditionally recognized for their heat-clearing and detoxifying properties.

Brand names
Yinqiao Jiedu Granules
Other names
Yin Qiao Jie Du Ke Li银翘解毒颗粒
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)HSP90AA1 (Heat shock protein HSP90-alpha)IL-6 (Interleukin 6)NFKBIA (NFKB inhibitor alpha)MYD88 (Myeloid differentiation primary response protein MyD88)RELA (Nuclear Factor Kappa B Subunit p65)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)STAT3 (Signal Transducer and Activator of Transcription 3)TLR7 (Toll-like receptor 7)mTOR (Mammalian target of rapamycin kinase)

Beyond the preview

Go deeper on Yinqiao Jiedu Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yinqiao Jiedu Granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call